Rise Baking Company Triumphs at 2025 National Pie Championships, Winning 23 Blue Ribbons from American Pie Council
MINNEAPOLIS, April 17, 2025 /PRNewswire/ -- Rise Baking Company, home to some of the most trusted brands in the baking industry, announced today an exciting achievement at the 2025 American Pie Council (APC) National Pie Championships, held April 14-15 in Orlando. Rise is proud to have been awarded 23 Blue Ribbons at the 28th annual event, securing its position among the best pie manufacturers.
This year's competition was intense, with hundreds of pies submitted by amateur, professional and commercial bakers across the U.S. and Canada. A panel of distinguished judges evaluated each entry based on first impressions, flavor, texture, mouthfeel, and overall appeal. Rise stood out from the competition, earning top honors across multiple categories in the commercial division including No Sugar Added, Handheld, Family, Premium, and Gourmet. Rise received accolades for beloved everyday flavors like apple, buttermilk, and peach, as well as for a new lineup of clean-label fruit pies and inventive varieties such as apple cranberry oat, hot honey peach, and vanilla chai pumpkin.
'Participating in the APC National Pie Championships for the first time is a tremendous opportunity to showcase the quality and flavor of our expanded product portfolio,' said Michael Docherty, SVP Marketing and R&D of Rise Baking Company. 'These wins are a testament not only to our commitment to quality, but also to the passion and hard work of our R&D team, whose dedication continues to push the boundaries of what's possible in baking.'
Rise acquired Worcester, Massachusetts-based Table Talk in June 2024, growing its slice of the pie industry with one of the country's leading full-line pie producers. The company's diverse portfolio of ready-to-bake, thaw & sell and mini snack pies includes a wide array of styles such as double-crust fruit, lattice, puree & custard, and crumb-topped pies, setting the standard for the perfect pie offerings for all occasions.
Specializing in cakes, cookies, muffins, icings, pies, and more, Rise produces a variety of products for in-store bakeries and foodservice clients, including leading national grocery chains, convenience stores, QSRs, and mass merchandisers. The company helps customers grow their businesses by offering an extensive lineup of products and unparalleled support through industry expertise.
For additional information on Rise Baking Company, visit risebakingcompany.com.
About Rise Baking Company:
Formed in 2013, Rise Baking Company is a North American bakery manufacturer headquartered in Minneapolis, MN. Rise produces a variety of products for in-store bakeries and foodservice clients, including leading national grocery chains, convenience stores, QSRs, and mass merchandisers. Specializing in cakes, cookies, muffins, icings, pies, and more, Rise brings together some of the most trusted brands in the industry, including Brill, South Coast Baking, Table Talk, Best Maid, Henry & Henry, Bakestone Brothers, among others. Their finest ingredient is their people, who are dedicated to partnering with customers to create special moments. For more information, visit risebakingcompany.com.
Media Contact:
Phase 3 Marketing & Communications
[email protected]
Brand Photography HERE
View original content to download multimedia: https://www.prnewswire.com/news-releases/rise-baking-company-triumphs-at-2025-national-pie-championships-winning-23-blue-ribbons-from-american-pie-council-302431034.html
SOURCE Rise Baking Company
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
an hour ago
- Time Business News
Shaping the Future of Leadership: The Strategic Role of C-Suite Executive Recruiters in NYC's Innovation Economy
New York City is more than just a business hub—it's a breeding ground for innovation. From fintech startups in Flatiron to global media empires headquartered in Midtown, the city pulses with disruption, reinvention, and opportunity. But behind every transformative business model is a leadership team equipped to execute with clarity and conviction. That's why C-suite executive recruiters in NYC have become indispensable partners to organizations looking to build forward-thinking, high-impact leadership teams. As NYC continues to position itself as a global leader in technology, sustainability, life sciences, and AI-driven enterprise, the profile of its executive leaders is shifting. Today's CEOs, CFOs, CMOs, and CTOs must not only bring proven management expertise—they must also possess the vision to navigate uncharted terrain. Traditional leadership search models aren't always equipped to address these evolving demands. That's where niche C-suite executive recruiters in NYC come in. These firms specialize in identifying talent who are not just functional leaders but are also fluent in innovation, adaptable to change, and capable of aligning with both investor expectations and market disruptions. NYC companies operate at breakneck speed. Whether in finance, media, health tech, or retail, market shifts happen rapidly—and leadership decisions must keep pace. But that doesn't mean companies can afford to cut corners when hiring for the C-suite. Every executive hire affects company culture, investor confidence, and long-term strategy. Executive recruiters mitigate this risk by offering both speed and precision. They leverage deep networks, proprietary search methodologies, and psychological assessments to vet candidates not only for technical fit, but also for values alignment and long-term leadership potential. In a city where the wrong hire can make headlines—and the right one can shape an industry—this level of rigor matters. One of the most valuable assets C-suite executive recruiters in NYC bring to the table is access to passive talent—executives who are not actively job-hunting but are open to compelling, strategically aligned opportunities. These individuals rarely respond to job postings or recruiter cold calls. Instead, they rely on trusted relationships and discreet introductions. Recruiters with long-standing reputations in NYC's leadership circles know how to initiate these conversations, build trust, and guide top candidates through complex, high-stakes transitions. Another area where modern C-suite recruiters are having a tangible impact is in advancing leadership diversity. In an increasingly global and socially conscious market, companies are under pressure to build executive teams that reflect the diverse perspectives of their customer base, employees, and investors. The best NYC-based recruiters proactively cultivate diverse candidate pipelines and advise companies on how to remove bias from their hiring processes. This not only strengthens brand reputation but also enhances business outcomes. Studies consistently show that diverse leadership teams drive better innovation and financial performance—a critical advantage in NYC's competitive sectors. As a leading name among C-suite executive recruiters in NYC, BCL Search brings a modern, strategic approach to leadership hiring. By combining deep market insight, long-standing industry relationships, and a highly personalized search process, they help companies build leadership teams that are not just ready for today—but equipped for the future. Whether you're seeking a transformational CEO or a digitally savvy CMO, BCL Search delivers the strategic partnership needed to secure world-class executive talent. TIME BUSINESS NEWS
Yahoo
an hour ago
- Yahoo
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. A heated debate over the U.S. healthcare system erupted on X, pitting billionaire entrepreneur Mark Cuban against Sen. Elizabeth Warren (D-Mass) over the root causes of soaring drug prices. What Happened: The clash, unfolding as of Friday, has reignited discussions on Pharmacy Benefit Managers (PBMs) and Big Pharma's tax practices, with the Senate poised to address reform amid rising public scrutiny. Enter Cuban, the Dallas Mavericks owner and founder of Cost Plus Drugs, who fired back with a pointed correction. Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — In a post quoting Warren, Cuban argued that PBMs—not Big Pharma—are the true culprits behind inflated drug prices. 'PBMs corrupt healthcare,' he wrote, explaining that these intermediaries control formularies and manipulate prices to maximize rebate revenue, with three major PBMs negotiating over 90% of rebates for commercial insurance plans. Warren, in her post, had blamed pharmaceutical giants like Johnson & Johnson (NYSE:JNJ) and Pfizer Inc. (NYSE:PFE) for charging Americans the 'highest drug prices in the world' while paying 'zero dollars in federal taxes.' Citing data from her Senate Finance Committee role, Warren highlighted how these companies, alongside AbbVie Inc. (NYSE:ABBV), Amgen Inc. (NASDAQ:AMGN), and Merck & Co Inc. (NYSE:MRK), have exploited tax loopholes from the 2017 Tax Cuts and Jobs Act to shield billions in profits. 'Republicans want to make it worse. I'm fighting back,' she declared, sharing a CNBC headline and urging action against what she calls a 'rigged tax system.' Why It Matters: Cuban has been a critic of the healthcare system, saying that it should be simple. According to him, it's become overly complicated by big insurance companies and PBMs. These groups, he says, act as middlemen, controlling not just the costs but also the accessibility of care. He blames PBMs for lack of transparency, inflated specialty drug prices, rebate distortion, formulary restrictions, and 'Sh–ing on' on independent pharmacies. Some significant firms engaged in the PBM business listed in the U.S. include;Stocks YTD Performance One Year Performance CVS Health Corp. (NYSE:CVS) 51.15% 9.57% Cigna Group. (NYSE:CI) 14.54% -6.95% UnitedHealth Group Inc. (NYSE:UNH) -39.11% -36.60% Meanwhile, here is how some pharmaceutical sector ETFs have performed;Pharma ETFs YTD Performance One Year Performance VanEck Pharmaceutical ETF (NASDAQ:PPH) 1.69% -4.48% iShares US Pharmaceuticals ETF (NYSE:IHE) -0.49% -1.85% Invesco Pharmaceuticals ETF (NYSE:PJP) -3.23% -1.64% SPDR S&P Pharmaceuticals ETF (NYSE:XPH) -4.06% 2.61% KraneShares MSCI All China Health Care Index ETF (NYSE:KURE) 20.55% 22.94% First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) -5.44% -6.27% Direxion Daily Pharmaceutical & Medical (NYSE:PILL) -23.49% -14.63% The SPDR S&P 500 ETF Trust (NYSE:SPY) and Invesco QQQ Trust ETF (NASDAQ:QQQ), which track the S&P 500 index and Nasdaq 100 index, respectively, were mixed in premarket on Friday. The SPY was down 0.30% at $595.67, while the QQQ was 0.015% higher at $529.07, according to Benzinga Pro data. Read Next: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Back a bold new approach to cancer treatment with high-growth potential. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo courtesy: Shutterstock This article Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
an hour ago
- Business Insider
Mistral AI CEO says AI's biggest threat is people getting lazy
As tech leaders continue to debate the potential impact of artificial intelligence on the job market, one CEO says the technology's biggest risk may be "deskilling." In an interview with The Times of London, Arthur Mensch, the CEO of the Paris-based firm Mistral AI, dismissed the idea that AI would lead to huge cuts to white-collar jobs, saying the bigger risk was that people may become progressively lazier as they increasingly rely on the tech to search for information. Speaking to the outlet at the VivaTech conference in Paris earlier this month, Mensch, who cofounded the open-source large language model developer alongside Guillaume Lample and Timothée Lacroix in April 2023, said that a key way to avoid this would be to ensure humans remained actively involved in reviewing and critiquing AI output. "It's a risk that you can avoid, if you think of it from a design perspective, if you make sure that you have the right human input, that you keep the human active," he said, adding that he believed it was important humans did not take AI output as the "truth." "You want people to continue learning," he continued. "Being able to synthesize information and criticize information is a core component to learning." Mensch, a former Google DeepMind researcher, also responded to recent warnings that AI poses a threat to white-collar jobs, including from Anthropic CEO Dario Amodei, who recently said that AI could replace half of all entry-level white-collar jobs within five years. "I think it's very much of an overstatement," Mensch said, adding that he believed Amodei liked to "spread fear" about AI as a marketing tactic. Instead, Mensch said he thought AI would change white-collar jobs. "I do expect that we'll have more relational tasks because that's not something you can easily replace," he said.
